These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28712518)

  • 1. Subclinical Atherosclerosis in Youth: Relation to Obesity, Insulin Resistance, and Polycystic Ovary Syndrome.
    Mendizábal B; Urbina EM
    J Pediatr; 2017 Nov; 190():14-20. PubMed ID: 28712518
    [No Abstract]   [Full Text] [Related]  

  • 2. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do women with polycystic ovary syndrome really have predisposition to atherosclerosis?
    Topcu S; Caliskan M; Gullu H; Ozcimen EE; Erdogan D; Uckuyu A; Zeyneloglu H; Muderrisoglu H
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):164-7. PubMed ID: 16638042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences.
    Kousta E; Tolis G; Franks S
    Hormones (Athens); 2005; 4(3):133-47. PubMed ID: 16613823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of isoprostanes in polycystic ovary syndrome and its relationship with cardiovascular risk factors.
    Calzada M; López N; Noguera JA; Mendiola J; Torres AM
    J Endocrinol Invest; 2019 Jan; 42(1):75-83. PubMed ID: 29687417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children.
    Kamangar F; Okhovat JP; Schmidt T; Beshay A; Pasch L; Cedars MI; Huddleston H; Shinkai K
    Pediatr Dermatol; 2015; 32(5):571-8. PubMed ID: 25787290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity--but not a PCOS-associated phenomenon.
    Ketel IJ; Stehouwer CD; Henry RM; Serné EH; Hompes P; Homburg R; Smulders YM; Lambalk CB
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4566-75. PubMed ID: 20660051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management.
    Janez A; Herman R; Poredos P; Mikhailidis DP; Blinc A; Sabovic M; Studen KB; Jezovnik MK; Schernthaner GH; Anagnostis P; Antignani PL; Jensterle M
    Curr Vasc Pharmacol; 2023; 21(6):424-432. PubMed ID: 37779406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The polycystic ovary syndrome--metabolic consequences].
    Tan S; Hahn S; Janssen OE
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
    Bajuk Studen K; Jensterle Sever M; Pfeifer M
    Front Horm Res; 2013; 40():64-82. PubMed ID: 24002406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive approach in diagnosing the polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Womens Health (Lond); 2015 Jul; 11(4):501-12. PubMed ID: 25756387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
    Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
    J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine abnormalities. Foreword.
    Schapiro NA
    Curr Probl Pediatr Adolesc Health Care; 2013; 43(5):103. PubMed ID: 23582591
    [No Abstract]   [Full Text] [Related]  

  • 14. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis.
    Mor E; Zograbyan A; Saadat P; Bayrak A; Tourgeman DE; Zhang C; Stanczyk FZ; Paulson RJ
    Am J Obstet Gynecol; 2004 Jun; 190(6):1654-60. PubMed ID: 15284763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome in obese adolescents.
    Stanley T; Misra M
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):30-6. PubMed ID: 18185060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
    Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
    Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic Ovarian Syndrome: Long-Term Health Consequences.
    Zore T; Joshi NV; Lizneva D; Azziz R
    Semin Reprod Med; 2017 May; 35(3):271-281. PubMed ID: 28658711
    [No Abstract]   [Full Text] [Related]  

  • 19. Adiposity in polycystic ovary syndrome: excess versus dysfunction.
    Azziz R
    Fertil Steril; 2021 Jul; 116(1):87-88. PubMed ID: 34034909
    [No Abstract]   [Full Text] [Related]  

  • 20. Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.
    Escobar-Morreale HF; Villuendas G; Botella-Carretero JI; Sancho J; San Millán JL
    Diabetologia; 2003 May; 46(5):625-33. PubMed ID: 12739017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.